| 1 |
Consideration of the Company's 2025 Annual Report containing the consolidated management report and independent auditors report on the Company's consolidated financial statements as of December 31, 2025; and the Company's annual accounts as of December 31, 2025 and the independent auditors report thereon. Approval of the Company's consolidated financial statements as of December 31, 2025 and 2024 and for the years ended December 31, 2025, 2024 and 2023. |
✓ For(84.106)
|
| 2 |
Consideration of the independent auditor's report on the Company's annual accounts. Approval of the Company's annual accounts as at December 31, 2025. |
✓ For(84.106)
|
| 3 |
Allocation of results for the year ended December 31, 2025. |
✓ For(84.106)
|
| 4 |
Discharge of members of the Board of Directors for the exercise of their mandate during the year ended December 31, 2025. |
✓ For(84.106)
|
| 5 |
Election of the members of the Board of Directors. |
✗ Against(84.106)
|
| 6 |
Authorization of the compensation to the members of the Board of Directors for the year 2026. |
✓ For(84.106)
|
| 7 |
Appointment of the independent auditors for the fiscal year ending December 31, 2026, and approval of their fees. |
✓ For(84.106)
|
| 8 |
Authorization to the Company, or any subsidiary, from time to time to purchase, acquire or receive securities of the Company, in accordance with Article 430-15 of the Luxembourg law of 10 August 1915 on commercial companies, as amended (the “Company Law”) and with applicable laws and regulations. |
✓ For(84.106)
|
| 9 |
Authorization to the Board of Directors to appoint one or more of its members as the Company’s attorney-in-fact. |
✓ For(84.106)
|